Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects

Autor: Taskinen, Marja-Riitta, Björnson, Elias, Andersson, Linda, Kahri, Juhani, Porthan, Kimmo, Matikainen, Niina, Söderlund, Sanni, Pietiläinen, Kirsi, Hakkarainen, Antti, Lundbom, Nina, Nilsson, Ralf, Ståhlman, Marcus, Adiels, Martin, Parini, Paolo, Packard, Chris, Borén, Jan
Zdroj: In Journal of Clinical Lipidology January-February 2020 14(1):77-87
Databáze: ScienceDirect